Intellivent ASV in Chronic Obstructive Pulmonary Disease Patients in the ICU

NCT02651935 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2021-07-29

No results posted yet for this study

Summary

This study will evaluate the effect of a fully closed loop ventilation mode (Intellivent ASV) on the duration of ventilation compared to conventional modes in COPD patients.

Conditions

Interventions

DEVICE

Intellivent ASV

Automated Invasive mechanical ventilation and weaning strategy

Sponsors & Collaborators

  • Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital

    lead OTHER

Principal Investigators

  • Ilknur Naz · Izmir Chest Diseases and Surgery Training Hospital

  • Burcu CINLETI · Izmir Chest Diseases and Surgery Training Hospital

  • Huseyin OZKARAKAS · Izmir Chest Diseases and Surgery Training Hospital

  • Tunzala YAVUZ · Izmir Chest Diseases and Surgery Training Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02651935 on ClinicalTrials.gov